Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07285954 · ClinicalTrials.gov registry record · NA
Mindfulness Walking Intervention to Enhance Resilience (iWalk)
A NA study of Mindfulness and Neuro-Degenerative Disease, sponsored by University of Illinois at Urbana-Champaign.
- Recruiting
- Registry status
- NA
- Development phase
- 90
- Enrollment target
- 1
- Study location
NCT07285954: Recruiting NA study of Mindfulness and Neuro-Degenerative Disease, sponsored by University of Illinois at Urbana-Champaign.
NCT07285954 is a NA study of Mindfulness and Neuro-Degenerative Disease that is actively recruiting participants, run by University of Illinois at Urbana-Champaign. The registered enrollment target is 90 participants, below the 140-participant average among 15 other Mindfulness trials with a reported enrollment target (36% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07285954, a NA study of Mindfulness and Neuro-Degenerative Disease, is actively recruiting participants, sponsored by University of Illinois at Urbana-Champaign.
- RECRUITING
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is a randomized controlled trial of the walking meditation intervention (iWalk) program, a multi-component intervention integrating walking meditation, education, and group sessions designed to enhance resilience in individuals with multiple sclerosis (MS). The objectives are to evaluate: 1. Recruitment capability and retention rates, 2. Acceptability and adherence to the intervention, 3. Feasibility of assessment procedures, and 4. Preliminary effects on psychological, physiological, and behavioral outcomes.
Conditions Studied
Interventions
- BEHAVIORAL iWalk Program
Study Locations (1)
Illinois
- University of Illinois Urbana-Champaign - Urbana
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2025-06-01 |
| Est. Completion | 2029-12-31 |
| Phase | NA |
What NCT07285954 shows while recruiting
NCT07285954 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 90 participants, a relatively small participant target, below the 140-participant average among 15 other Mindfulness trials with a reported enrollment target (36% lower).
The record links to 4 conditions, with Mindfulness appearing as the primary indexed condition, and to 1 intervention - of which iWalk Program is the first listed.
NCT07285954 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT07285954 about?
NCT07285954 is a clinical study titled "Mindfulness Walking Intervention to Enhance Resilience (iWalk)". This study is a randomized controlled trial of the walking meditation intervention (iWalk) program, a multi-component intervention integrating walking meditation, education, and group sessions designed to enhance resilience in individuals with multiple sclerosis (MS). The objectives are to evaluate...
What is the current status of trial NCT07285954?
This trial is currently recruiting. It is a NA study. The enrollment target is 90 participants. The study started on 2025-06-01. Estimated completion is 2029-12-31.
What conditions does trial NCT07285954 study?
This clinical trial studies the following conditions: Mindfulness, Neuro-Degenerative Disease, Adults, EEG.
What interventions are being tested in trial NCT07285954?
The interventions under investigation include: iWalk Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT07285954?
This trial is sponsored by University of Illinois at Urbana-Champaign, which has 129 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07285954 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Mindfulness
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07285954's enrollment target sits among peer trials
90 6th of 15 higher than 10 of 15 other Mindfulness trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Mindfulness trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Mindfulness to Enhance Cognitive Health in Latinx Older Adults
RECRUITING · NA
-
Mindfulness and Meditation Based Lactation Education on Maternal Breastmilk in the Neonatal ICU
RECRUITING · NA
-
Mind-body Resilience Program for Cardiac Arrest Survivors and Their Caregivers: Recovering Together After Cardiac Arrest
RECRUITING · NA
-
Eastern Principles Acceptance and Commitment Therapy For Injury Prevention Among Nurses and Nursing Aides
RECRUITING · NA
-
Feasibility of a Mindfulness Intervention for Endometriosis Surgery
RECRUITING · NA
-
Online Mindfulness-based Program for Parents of Children With Autism
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI